Влияние ?-казоморфинов на материнско-детское взаимодействие белых крыс
Диссертация
Наше исследование в значительной своей части посвящено анализу последствий однократного введения Р-казоморфинов детенышам крыс. При этом удалось обнаружить возрастные интервалы, на которых проявляются (начинают себя проявлять) различные компоненты нейротропного действия гептапептида Р-казоморфина-7 — основного представителя соединений этой группы. Снижение болевой чувствительности обнаружено… Читать ещё >
Список литературы
- Аничков C.B. Нейрофармакология. // JI. Медицина. — 1982. — 384 с.
- Ашмарин И.П., Каразеева Е. П. Нейропептиды. // В: «Биохимия мозга». ред. И. П. Ашмарин, П. В. Стукалов, Н. Д. Ещенко. — СПб.: Изд-во Санкт-Петербургского университета. — 1999. — с. 232−266.
- Ашмарин И.П., Каразеева Е. П., Стукалов П. В. Биохимические исследования механизмов психических и нервных болезней. // там же. с. 296−317.
- Беспалов А.Ю., Звартау Э. Э. Нейропсихофармакология антагонистов NMDA-рецепторов. // Спб., Невский диалект. 2000. — 297 с.
- Буреш Я., Бурешова О., Хьюстон Д. П. Методики и основные эксперименты по изучению мозга и поведения. // М. Высшая школа. — 1991. — 399 с.
- Власова Т.Н., Каменский A.A., Ашмарин И. П. Влияние лей-энкефалинов на обучение белых крыс в Т-образном лабиринте. // Журнал ВНД им. И. П. Павлова. -1983. т. 33.-№ 5. — с. 870−876.
- Девойно JI.B., Ильюченок Р. Ю. Нейромедиаторные системы в психонейро-иммуномодуляции. // ЦЭРИС, Новосибирск. 1993. — 240 с.
- Динзбург A. JL, Чирков А. М., Чиркова С. К. Стресс-протекторное действие нейропептидов на обезьян. // Патол. физиол. эксперим. терапия. 1995. — № 1- - с. 19−21.
- Дмитриева Н.И., Кассиль В. Г. Вляние неонатальной изоляции от матери на общее развитие, формирование мозга и поведение. // Физиол. журнал им. И. М. Сеченова. -1994.т. 80.-№ 8.-с. 63−71.
- Дубынин В.А., Маклакова A.C., Алфеева Л. Ю., Незавибатько В. Н., Каменский A.A., Ашмарин И. П. Действие бета-казоморфина-7 на ноцицепцию крыс при системном введении. // Бюлл. эксперим. биол. и мед. 1992.- № 9.- с. 284−286.
- Дубынин В.А., Асмакова Л. С., Соханенкова Н. Ю., Беспалова Ж. Д., Незавибатько В. Н., Каменский A.A. Сравнительный анализ нейротропной активности экзорфинов производных пищевых белков. // Бюлл. эксперим. биол. и мед. — 1998. — т. 125. -№ 2.-с. 153−157.
- Дубынин В.А. Постнатальная нейротропная активность ß--казоморфинов (регуляция поведения взрослых и новорожденных млекопитающих). // Дисс. на соискание ученой степени доктора биол. наук. М., 2001. 387 с.
- Зуфаров К.А. Новые данные о пищеварительно-всасывательных функциях тонкойкишки и почек новорожденных. // Бюллетень экспериментальной биологии и медицины. 1998. — т. 125. — № 1. — с. 4−11.
- Конь И.Я., Рациональное вскармливание и здоровье детей: современные аспекты. // Росс, педиатр, журнал. 1999. — N2. — с. 45−48.
- Косенкова Н.С., Пошивалов В. П. Влияние агонистов и антагонистов опиатных рецепторов на материнскую агрессию крыс. // Бюлл. эксперим. биол и медицины. -1989. т. 107. — № 2. — с. 207−209.
- Малиновская И.В. Нейротропные эффекты р-казоморфина-7 при хроническом и остром введении детенышам белых крыс. // Дисс. на соискание ученой степени канд. биол. наук. М., 2001. — 186 с.
- Маклакова A.C., Дубынин В. А., Левицкая Н. Г., Незавибатько В. Н., Алфеева Л. Ю., Каменский A.A., Ашмарин И. П. Поведенческие эффекты бета-казоморфина-7 и его дез-Туг-аналогов // Бюлл. эксперим. биол. и мед. 1993.- № 8.- с.155−158.
- Маклакова A.C., Дубынин В. А., Алфеева Л. Ю., Назаренко И. В., Незавибатько В. Н., Каменский A.A. Действие бета-казоморфина-7 на различные виды обучения белых крыс // Бюлл. эксперим. биол. и мед. 1995.- т. 120.- № 11.- с.499−502.
- Маклакова A.C. Нейротропные эффекты фрагмента ß--казеина молока -гептапептида р-казоморфина-7. // Дисс. на соискание ученой степени канд. биол. наук. М., 1996.- 188 с.
- Маклакова A.C., Дубынин В. А., Андреева Л. А., Алфеева Л. Ю. Каменский A.A. Нейротропное действие р-казоморфина-7 на фоне фармакологического изменения состояния мозга крыс. // Вестник Московского Университета. Сер. 16, Биология. -1999.-№ 1.-C.3−9.
- Машковский М.Д. Лекарства XX века. // М. Медицина. — 1998. — 320 с.
- Пошивалов В Л., Косенкова Н. С. Этологическое исследование последствий пренатального введения психотропных препаратов. // Фармакол. токсикол. 1989. -т. 52.-№ 5.-с. 99−107.
- Симонов П.В. Психофизиология эмоций. // В: «Основы психофизиологии». М., Инфра-М. — 1997. — с. 143−167.
- Соломзес Д. А., Чеурсон В. Соколовский Г. Наркотики и общество. // М. -«Иллойн». 1998. -192 с.
- Суворов Н.Ф., Якимовский А. Ф. Роль энкефалин-реактивной системы хвостатого ядра в формировании пищевого условного рефлекса у собак. // Журнал ВНД им. И .П .Павлова. 1982. — т. 32. — № 5. — с. 840−844.
- Agmo A., Barreau S., Lemaire V. Social motivation in recently weaned rats is modified by opiates. // Dev. Neurosci. 1997. — v. 19(6). — p. 505−520.
- Agmo A., Beizung C. The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide. // Neuropharmacology. 1998. — v. 37(2). — p. 223−232.
- Aicher S.A., Mitchell J.L., Swanson K.C., Zadina J.E. Endomorphin-2 axon terminals contact mu-opioid receptor-containing dendrites in trigeminal dorsal horn. // Brain Res. -2003. v. 977(2). — p. 190−198.
- Alexander L.J., Das Gupta N.A., Beattie C.W. The sequence of porcine alpha s2-casein cDNA. // Anim. Genet. 1992. — v.23. — p. 365−367.
- Allescher H.D., Storr M., Piller C., Brantl V., Schusdziarra V. Effect of opioid active therapeutics on the ascending reflex pathway in the rat ileum. // Neuropeptides. 2000. -v. 34(3−4).-p. 181−186.
- Asakawa A., Inui A., Momose K., Ueno N., Fujino M.A., Kasuga M. Endomorphins have orexigenic and anxiolytic activities in mice. // Neuroreport. 1998. -v. 13. — p. 2265−2267.
- Auestad N., Fisher R., Chiappelli F., Korsak R.A., Edmond J. Growth and development of brain of artificially reared hypoketonemic rat pups. // Proc. Soc. Exp. Biol. Med. 1990. -v. 195(3).-p. 335−344.
- Balaban C.D., Thayer J: F. Neurological bases for balance-anxiety links. // J. Anxiety Disord. 2001. — v. 15(1−2). — p. 53−79.
- Banks W.A., Kastin A.J. Peptide transport systems for opiates across the blood-brain barrier. // Am. J. Physiol." — 1990. v. 259.-p. 1−10.
- Banks W.A., Kastin A.J., Harrison L.M., Zadina J.E. Perinatal treatment of rats with opiates affects the development of the blood-brain barrier transport system PTS-1. // Neurotoxicol. Teratol. 1996. — v. 18(6). -p. 711−715.
- Barr G.A., Paredes W., Erickson K.L., Zukin R.S. Kappa opioid receptor-mediated analgesia in the developing rat. // Brain Res. 1986. — v. 394(2). — p. 145−152.
- Behavioural Neuroscience. A practical approach. // Ed. by Saghal A. Oxford Univ. Press.- 1993.-v. 1.-218 p.
- Behavioural Neuroscience. A practical approach. 7/ Ed. by Saghal A. Oxford Univ. Press. — 1993.-v. 2.-217 p.
- Besson A., Privat A.M., Eschalier A., Fialip J. Effects of morphine, naloxone and their interaction in the learned-helplessness paradigm in rats. // Psychopharmacology (Berl.). -1996.-v. 123(1).-p. 71−78.
- Blass E.M., Blom J. Betata-casomorphin causes hypoalgesia in 10-day-old rats: evidence for central mediation. // Pediatr. Res. 1996. — v. 39(2). — p. 199−203.
- Boyer P. Do anxiety and depression have a common pathophysiological mechanism? // Acta Psychiatr. Scand. 2000. — Suppl.(406). — p. 24−29.
- Brantl V., Neubert K. Opioid peprides derived from food proteins // TJPS. 1986. — v. 7. -p. 6−7.
- Brantl V., Teschemacher H., Blasig J., Henschen A., Lottspeich F. Opioid activities of beta-casomorphins. // Life Sci. 1981. — v. 28(17). — 1903−1909.
- Brantl V., Teschemacher H., Henschen A., Lottspeich F. Novel opioid peptides derived from casein (beta-casomorphins). I. Isolation from bovine casein peptone. // Hoppe Seylers. Z. Physiol. Chem. 1979. — v. 360(9). — p. 1211−1216.
- Bremner J.D., Krystal J.H., Southwick S.M., Charney D.S. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. // Synapse. 1996. — v. 23(1). — p. 28−38.
- Bridges R.S., Millard W.J. Growth hormone is secreted by ectopic pituitary grafts and stimulates maternal behavior in rats.// Horm Behav.-1988.- Jun.-v.22(2).-p. 194−206
- Buwalda B., Nyakas C., Koolhaas J.M., Bohus B. Effects of neonatal administration of vasopressin on cardiac and behavioral responses to emotional stress in adult male rats. // Physiol. Behav. 1991. — v. 50(5). — 929−932.
- Byrnes E.M., Rigero B.A., Bridges R.S. Opioid receptor antagonism during early lactation results in the increased duration of nursing bouts. // Physiol Behav. 2000. — v. 70(1−2). -p.211−216.
- Castellano C., Ammassari-Teule M. Prenatal exposure to morphine in mice: enhanced responsiveness to morphine and stress. // Pharmacol. Biochem. Behav. 1984. — v. 21(1). -p. 103−108.
- Chang K.J., Lillian A., Hazum E., Cuatrecasas P., Chang J.K. Morphiceptin (NRt-tyr-pro-phe-pro-COHN2): a potent and specific agonist for morphine (mu) receptors. // Science. -1981. v. 212(4490). — p. 75−77.
- Chang K.J., Su Y.F., Brent D.A., Chang J.K. Isolation of a specific mu-opiate receptor peptide, morphiceptin, from an enzymatic digest of milk proteins. // J. Biol. Chem. 1985. -v. 260(17).-p. 9706−9712.
- Charlin V., Defilippi C., Vargas V., Borghesi L., Gomez E. Treatment of acute secretory diarrhea with casein: an effect of beta-casomorphins? // Rev. Med. Chil. 1992. — v. 120(6). — p. 666−669.
- Charney D.S., Deutch A. A functional neuroanatomy of anxiety and fear: implications for the pathophysiology and treatment of anxiety disorders. // Crit. Rev. Neurobiol. 1996. -v. 10(3−4).-p. 419−446.
- Corbett A.D., Gillan M.G., Kosterlitz H.W., McKnight A.T., Paterson S.J., Robson L.E. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor. // Br. J. Pharmacol. 1984. — v. 83(1). — p. 271−279.
- Coudereau J.P., Debray M., Monier C., Bourre J.M., Frances H. Isolation impairs place preference conditioning to morphine but not aversive learning in mice. // Psychopharmacology (Berl.). 1997. — v. 130(2). — p. 117−123.
- Cuomo V., Cagiano R., De Salvia M.A., Restani P., Galimberti R., Colonna S., Racagni
- G., Galli C.L. Ultrasonic vocalization in rat pups as a marker of behavioral development: an investigation of the effects of drugs influencing brain opioid system. // Neurotoxicol. Teratol. 1988. — v. 10(5). — p. 465−469.
- Daniel H., Vohwinkel M., Rehner G. Effect of casein and beta-casomorphins on gastrointestinal motility in rats. // J. Nutr. 1990. — v. 120(3). — p. 252−257.
- Dauge V. Neurobiological impact of separating mothers from newborns in rodents. // MedSci (Paris). 2003.- v, 19(5).-p.607−611.
- De Ponti F., Marcoli M., Lecchini S., Manzo L., Frigo G.M., Crema A. Effect of beta-casomorphins on intestinal propulsion in the guinea-pig colon: // J. Pharm. Pharmacol. -1989. -v. 41(5). -p. 302−305.
- Engelmann M., Wotjak C.T., Ebner K., Landgraf R. Behavioural impact of intraseptally released vasopressin and oxytocin in rats. // Exp. Physiol. 2000. — 85 Spec. No. — p. 125S-130S.
- Eppler C.M., Hulmes J.D., Wang J.B., Johnson B., Corbett M., Luthin D.R., Uhl G.R., Linden J. Purification and partial amino acid sequence of a mu opioid receptor from rat brain. // J. Biol. Chem. 1993. — v. 268(35). — p. 26 447−26 451.
- Ermisch A., Ruhle H.J., Neubert K., Hartrodt B., Landgraf R. On the blood-brain barrier to peptides: 3H. beta-casomorphin-5 uptake by eighteen brain regions in vivo. // J. Neurochem. 1983. — v. 41(5). — p. 1229−1233.
- Evans C.J., Keith D.E. Jr., Morrison H., Magendzo K., Edwards R.H. Cloning of a delta opioid receptor by functional expression. // Science. 1992. — v. 18. — p. 1952−1955.
- Fawcett J., Busch K.A., Jacobs D., Kravitz H.M., Fogg L. Suicide: a four-pathway clinical-biochemical model. // Ann. N Y Acad. Sci. 1997. — v. 836. — p. 288−301.
- Felicio L.F., Mann P.E., Bridges R. S Intracerebroventricular cholecystokinin infusions block beta-endorphin-induced disruption of maternal behavior. // Pharmacol. Biochem. Behav. 1991. — v. 39. — N 1. — p. 201−204.
- Fleming A.S., Anderson V. Affect and nurturance: mechanisms mediating maternal behavior in two female mammals. // Prog. Neuropsychopharmacol. Biol. Psychiatry. -1987.-v. 11(2−3).-p. 121−127.
- Freeman F.M., Young I.G. Inhibition of passive-avoidance memory formation in the day-old chick by the opioid cytochrophin-4. // Learn. Mem. 2000. — v. 7(4). — p. 213−219.
- Fukudome S., Jinsmaa Y., Matsukawa T., Sasaki R., Yoshikawa M. Release of opioid peptides, gluten exorphins by the action of pancreatic elastase. // FEBS Lett. 1997. — 412. — N3. — p. 475−479.
- Fukudome S., Yoshikawa M. Opioid peptides derived from wheat gluten: their isolation and characterization. // FEBS Lett. 1992. — v. 296(1). — p. 107−111.
- Fukudome S., Yoshikawa M. Gluten exorphin C. A novel opioid peptide derived from wheat gluten. // FEBS Lett. 1993.- v. 316(1). — p. 17−19.
- Gale J.S., Bird E.D., Spoke E.G., Ivejsen L.L., Jessel T. Human brain substance P: distribution in controls and Huntington’s chorea. // J. Neurochem. 1978. — v. 30(3). — p. 633−634.
- Georges F., Normand E., Bloch B., Le Moine C. Opioid receptor gene expression in the rat brain during ontogeny, with special reference to the mesostriatal system: an in situhybridization study. // Brain Res. Dev. 1998. — v. 109(2). — p. 187−199.
- Glamsta E.L., Meyerson B., Silberring J., Terenius L., Nyberg F. Isolation of a hemoglobin-derived opioid peptide from cerebrospinal fluid of patients with cerebrovascular bleedings. // Biochem. Biophys. Res. Commun. 1992. — v. 184(2). — p. 1060−1066.
- Greenberg R., Groves M.L., Dower H.J. Human beta-casein. Amino acid sequence and identification of phosphorylation sites. // J.Biol.Chem. 1984. — v. 259(8). — p. 5132−5138.
- Haileselassie S.S., Lee B.H., Gibbs B.F. Purification and identification of potentially bioactive peptides from enzyme-modified cheese. // J. Dairy Sci. 1999. — v. 82(8). — p. 1612−1617.
- Hall L., Laird J.E., Craig R.K. Nucleotide sequence determination of guinea-pig casein B mRNA reveals homology with bovine and rat alpha si caseins and conservation of the non-coding regions of the mRNA. // Biochem. J. 1984. — v. 222. — p. 561−570.
- Haney M., Miczek K.A. Morphine effects on maternal aggression, pup care and analgesia in mice. // Psychopharmacology (Berl.). 1989. — v. 98(1). — p. 68−74.
- Harrison L.M., Zadina J.E., Banks W.A., Kastin AJ. Effects of neonatal treatment with Tyr-MIF-1, morphiceptin, and morphine on development, tail flick, and blood-brain barrier transport. // Brain Res. Dev. Brain Res. 1993. — v. 75(2). — p. 207−212.
- Hasenohrl R.U., Schwarting R.K., Gerhardt P., Privou C., Huston J.P. Comparison of neurokinin substance P with morphine in effects on food-reinforced operant behavior and feeding. // Physiol. Behav. 1994. — v. 55(3). — p. 541−546.
- Hatzoglou A., Bakogeorgou E., Hatzoglou C., Martin P.M., Castanas E. Antiproliferative and receptor binding properties of alpha- and beta-casomorphins in the T47D human breast cancer cell line. // Eur. J. Pharmacol. 1996. — v. 310(2−3). — p. 217−223.
- Hedner J., Hedner T. beta-Casomorphins induce apnea and irregular breathing in adult rats and newborn rabbits. // Life Sci. 1987. — v. 41(20). — p. 2303−2312.
- Henning S.J. Maternal factors as determinants of food intake during the suckling period. // Int. J. Obes. 1980. — v. 4(4). — p. 329−332.
- Henschen A., Lottspeich F., Brantl V., Teschemacher H. Novel opioid peptides derived from casein (beta-casomorphins). II. Structure of active components from bovine casein peptone. // Hoppe Seylers Z. Physiol. Chem. 1979. -v. 360(9). — p. 1217−1224.
- Hill L.M., Kleinberg F. Effects of drugs and chemicals on the fetus and newborn. // Mayo Clin. Proc. 1984. — v. 59(11). — p. 755−765.
- Hosea N A., Miller G.P., Guengerich F.P. Elucidation of distinct ligand binding sites for cytochrome P450. // Biochemistry. 2000. — v. 39(20). — p. 5929−5939.
- Jinsmaa Y., Yoshikawa M. Enzymatic release of neocasomorphin and beta-casomorphin from bovine beta-casein. // Peptides. 1999. — v. 20(8). — p. 957−962.
- Eur. J. Pharmacol. 1997. — v. 335(2−3). — p. 255−265.
- Kappeler S., Farah Z., Puhan Z. Sequence analysis of Camelus dromedarius milk casein. // J. Dairy Res. 1998. — v. 65. — p. 209−222.
- Karelin A.A., Philippova M.M., Karelina E.V., Ivanov V.T. Isolation of endogenous hemorphin-related hemoglobin fragments from bovine brain. // Biochem. Biophys. Res. Commun. 1994. — 202 — N 1. — p. 410−415.
- Kent J.M., Coplan J.D., Gorman J.M. Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. // Biol. Psychiatry. 1998. — v. 44(9). — p. 812−824.
- Kieffer B.L., Befort K., Gaveriaux Ruff C., Hirth C.G. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. // Proc. Natl. Acad. Sci. USA. 1992. — v. 89(24). — p. 12 048−12 052.
- Kinney H.C., Ottoson C.K., White W.F. Three-dimensional distribution of 3H-naloxone binding to opiate receptors in the human fetal and infant brainstem. // J. Comp. Neurol.-1990.- v.291(l). p.55−78.
- Kinsley C.H., Bridges R.S. Opiate involvement in postpartum aggression in rats. // Pharmacol. Biochem. Behav. 1986. — v. 25(5). — p. 1007−1011.
- Kinsley C.H., Bridges R.S. Parity-associated reductions in behavioral sensitivity to opiates.//Biol. Reprod. 1988. — v. 39(2). — p. 270−278.
- Koch G., Brantl V. Binging of beta-casomorphins to opioid receptors. // In: Beta-casomorphins and related reptides (eds. Nyberg F., Brantl V.). Furis-Tryck AB, Uppsala. — 1990. — p. 43−52.
- Koch G.- Wiedemann K.- Drebes E.- Zimmermann W.- Link G.- Teschemacher H. Human beta-casomorphin-8 immunoreactive material in the plasma of women during pregnancy and after delivery. // Regul. Pept.- 1988. v. 20(2). — p. 107−117.
- Koch G., Wiedemann K., Teschemacher H. Opioid activities of human beta-casomorphins. // Naunyn Schmied. Arch. Pharmacol. 1985. — v.331(4). — p. 351−354.
- Kohler U., Rauca C. Effects of BCH 325 (Pro-D-Phe-Pro-Gly) on open field behavior after chronic stress procedure. // Peptides. 1992. — v. 13(1). — p. 141−144.
- Koks S., Soosaar A., Voikar V., Bourin M., Vasar E. BOC-CCK-4, CCK (B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze. // Neuropeptides. 1999. — v. 33(1). — p. 63−69.
- Koks S., Soosaar A., Voikar V., Volke V., Ustav M., Mannisto P.T., Bourin M., Vasar E. Opioid antagonist naloxone potentiates anxiogenic-like action of cholecystokinin agonists in elevated plus-maze. // Neuropeptides. 1998. — v. 32(3). — p. 235−240.
- Kosterlitz H.W., Paterson SJ. Types of opioid receptors: relation to antinociception. // Philos. Trans. R. Soc. Lond. B. Biol. Sci. 1985. — v. 308(1136). — p. 291−297.
- Kozlova M., Kalentchuk V. Stimulatory effect of opioid peptides and naloxone on rat spinal cord cells in primary dissociated culture. // Int. J. Dev. Neurosci. 1994. — v. 12(5). -p. 507−515.
- Lavecchia A., Greco G., Novellino E., Vittorio F., Ronsisvalle G. Modeling of kappa-opioid receptor/agonists interactions using pharmacophore-based and docking simulations. // J. Med. Chem. 2000. — v. 43(11). — p. 2124−2134.
- Lazarus L.H., Bryant S.D., Salvadori S., Attila M., Sargent Jones L. Opioid infidelity: // Trends. Neurosci. -1996. v. 19(1). — p. 31−35.
- Leboyer M., Bouvard M.P., Launay J.M., Recasens C., Plumet M.H., Waller-Perotte D., Tabuteau F., Bondoux D., Dugas M. Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone. // Encephale. 1993. — v. 19(2). — p. 95−102.
- Lee J, Chai SY, Mendelsohn FA, Morris MJ, Allen AM. Potentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7. // Neuropharmacology. 2001. — 40. — N 4. — p.618−623.
- Lee Y.S., Wurster R.D. Differential effects of methionine enkephalin on the growth of brain tumor cells. // J. Neurooncol. 1994. — v. 19(1). — p. 11−15.
- Lemieux L., Amiot J. High-performance liquid chromatography of casein hydrolysates phosphorylated and dephosphorylated. I. Peptide mapping. // J. Chromatogr. 1990. — v. 2.-p. 299−321.
- Leon M. Neuroethology of olfactory preference development. // J. Neurobiol. 1992. -v. 23(10).-p. 1557−1573.
- Liebmann C., Schrader U., Brantl V. Opioid receptor affinities of the blood-derived tetrapeptides hemorphin and cytochrophin. // Eur. J. Pharmacol. 1989. — v. 166(3). — p. 523−526.
- Liebmann C., Szucs M., Neubert K., Hartrodt B., Arold H., Barth A. Opiate receptor binding affinities of some D-amino acid substituted betai-casomorphin analogs. // Peptides. 1986. — v.7(2). — p. 195−199.
- Lin L., Umahara M., York D.A., Bray G.A. Beta-casomorphins stimulate and enterostatin inhibits the intake of dietary fat in rats. // Peptides. 1998. — v. 19(2). — p. 325−331.
- Lindner G., Grosse G., Wenzel M., Jentzsch K.D., Forner K., Oehme P. The effect of methionine enkephalin, leucine enkephalin and the hexapeptide, dalargin on the morphology of cultured neurons. // Hirnforsch. 1988. — v. 29(5). — p. 547−556.
- Lindstrom L.H.- Nyberg F.- Terenius L.- Bauer K.- Besev G.- Gunne L.M.- Lyrenas S.- Willdeck-Lund G.- Lindberg B. CSF and plasma beta-casomorphin-like bpioid peptides in postpartum psychosis. // Am. J. Psychiatry. 1984. — v. 141(9). — p. 1059−1066.
- Loukas S., Varoucha D., Zioudrou C., Streaty R.A., Klee W.A. Opioid activities and structures of alpha-casein-derived exorphins. // Biochemistry. 1983. — 22. — N 19. — p. 4567−4573.
- Mahe S., Dumontier A.-M., Tome D. Intestinal action and absorbtion of beta-casomorphins. In: Beta-Casomorphins and Related Peptides (Nyberg F. and Brantl V., ads.), Furis-Tryck AB, Uppsala, Sweden. -1990. p. 79−85.
- Mann P.E., Kinsley C.H., Bridges R.S. Opioid receptor subtype involvement in maternal behavior in lactating rats. // Neuroendocrinology. 1991. — v.53(5). — p. 487−492.
- Mann P.E., Bridges R.S. Neural and endocrine sensitivities to opioids decline as a function of multiparity in the rat. // Brain Res.- 1992.- v.580(l-2). p. 241−248.
- Maree L.V. Traite de la Folie des Femmes Enceintes. // De Nouvelles Accouchees et de Nourrices. Bailliere. — Paris, 1858.
- Martin-Schild S., Zadina J.E., Gerall A.A., Vigh S., Kastin A.J. Localization of endomorphin-2-like immunoreactivity in the rat medulla and spinal cord. // Peptides. -1997. v. 18(10). — p. 1641−1649.
- Matthies H., Ruthrich H.L., Stark H., Barth A., Neubert K., Hartrodt B. Deproceptin, Tyr-Pro-Phe-D-Pro-NH2, another casomorphin with remarkable analgesic action. // Acta Biol. Med. Ger. 1982. — v. 41(9). — p. K39−42.
- Matthies H., Stark H., Hartrodt B., Ruethrich H.L., Spieler H.T., Barth A., Neubert K. Derivatives of beta-casomorphins with high analgesic potency. // Peptides. 1984. -v.5(3). — p. 463−470.
- McDowell J., Kitchen I. Ontogenesis of delta-opioid receptors in rat brain using 3H. D-Pen2,D-Pen5] enkephalin as a binding ligand. // Eur. J. Pharmacol. 1986. — v. 128(3). — p. 287−289.
- Meisel H. Chemical characterization and opioid activity of an exorphin isolated from in vivo digests of casein. // FEBS Lett. 1986. — v. 196(2). — p. 223−227.
- Meisel H., FitzGerald RJ. Opioid peptides encrypted in intact milk protein sequences. // Br. J. Nutr. 2000. — Suppl. 1. — p. S27-S31.
- Miller J.H., Azmitia E.C. Growth inhibitory effects of a mu opioid on cultured cholinergic neurons from fetal rat ventral forebrain, brainstem, and spinal cord. // Brain Res. Dev. Brain Res. 1999. — v. 114(1). — p. 69−77.
- Minami M., Hosoi Y., Toya T., Katao Y., Maekawa K., Katsumata S., Yabuuchi K., Onogi T., Satoh M. In situ hybridization study of kappa-opioid receptor mRNA in the rat brain. // Neurosci. Lett. 1993. — v. 12. — p. 161 -164.
- Miranda-Paiva C.M., Ribeiro-Barbosa E.R., Canteras N.S., Felicio L.F. A role for the periaqueductal grey in opioidergic inhibition of maternal behaviour. // Eur J Neurosci. -2003. v. l8(3). — p.667−674.
- Mitsuma T., Nogimori T., Chaya M. Beta-casomorphin inhibits thyrotropin secretion in rats. // Exp. Clin. Endocrinol. 1984. — v. 84(3). — p. 324−330.
- Moeller I., Chai S.Y., Smith I., Lew R., Mendelsohn F.A. Haemorphin peptides may be endogenous ligands for brain angiotensin AT4 receptors. // Clin. Exp. Pharmacol. Physiol. -Suppl. 1998.-p. S68−71.
- Moffat S.D., Suh E.J., Fleming A.S. Noradrenergic involvement in the consolidation ofmaternal experience in postpartum rats. // Physiol. Behav. 1993. — v. 53(4). — p. 805−811.
- Molina V.A., Heyser C.J., Spear L.P. Chronic variable stress enhances the stimulatory action of a low dose of morphine: reversal by desipramine.// Eur. J. Pharmacol. 1994. -v. 260(1).-p. 57−64.
- Moore C.L., Power K.L. Prenatal stress affects mother-infant interaction in Norway rats. // Dev Psychobiol.- 1986. v. l9(3). — p.235−245
- Moore C.L., Wong L., Daum M.C., Leclair O.U. Mother-infant interactions in two strains of rats: implications for dissociating mechanism and function of a maternal pattern. // Dev. Psychobiol.- 1997. v.30(4). — p. 301−312.
- Motta V., Brandao M.L. Aversive and antiaversive effects of morphine in the dorsal periaqueductal gray of «rats submitted to the elevated plus-maze test. // Pharmacol. Biochem. Behav. 1993. — v. 44(1). — p. 119−125.
- Muehlenkamp M.R., Warthesen J.J. Beta-casomorphins: analysis in cheese and susceptibility to proteolytic enzymes from Lactococcus lactis ssp. cremoris. // J. Dairy Sci. 1996. — v. 79(1). — p. 20−26.
- Nairn M., Nicolas P., Baron D. Folded conformations of the delta-selective opioid dermenkephalin with head-to-tail interactions. A stimulated annealing stugy through NMR restraints. // Int. J. Pept. Protein Res. -1996. v. 47 (5). — p. 27−31.
- Nedvidkova J., Kasafirek E., Dlabac A., Felt V. » Effect of beta-casomorphin and its analogue on serum prolactin in the rat. // Exp. Clin. Endocrinol. 1985. — v. 85(2). — p. 249−252.
- Negri L., Lattanzi R., Melchiorri P. Production of antinociception by peripheral administration of Lys7. dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors. // Br. J. Pharmacol. 1995. — v. 114(1). — p. 57−66.
- Nelson E.E., Panksepp J. Brain substrates of infant-mother attachment: contributions of opioids, oxytocin, and norepinephrine. // Neurosci. Biobehav. Rev. 1998. — v. 22(3). — p. 437−452.
- Netter P., Hennig J., Huwe S. Explanatory models of anxiety from the viewpoint of biopsychology and pharmacopsychology. // Anasthesiol. Intensivmed. Notfallmed. Schmerzther. 1997. — v.32(3 Suppl). — p. S325−329.
- Noda M., Teranishi Y., Takahashi H., Toyosato M., Notake M., Nakanishi S., Numa S. Isolation and structural organization of the human preproenkephalin gene. // Nature. -1982. v. 297(5865). — 431−434.
- Nyberg F.- Lindstrom L.H.- Terenius L. Reduced beta-casein levels in milk samples from patients with postpartum psychosis. // Psychiatry. 1988. — v. 23(2). — p. 115−122.
- Pakaririen E.D., Woods J.H., Moerschbaecher J.M. Repeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist. // J. Pharmacol. Exp. Ther. 1995. — v. 272(2). — p. 552−559.
- Panigrahy A., Sleeper L.A., Assmann S., Rava L.A., White W.F., Kinney H.C. Developmental changes in heterogeneous patterns of neurotransmitter receptor binding in the human interpeduncular nucleus. // J. Comp. Neurol. 1998. — v. 390(3). — p. 322−332.
- Panksepp J., Nelson E., Siviy S. Brain opioids and mother-infant social motivation. // Acta Paediatr. 1994. — v. 397(1). — p. 40−46.
- Panksepp J., Normansell L., Siviy S., Rossi J. 3rd, Zolovick A.J. Casomorphins reduce separation distress in chicks. // Peptides. 1984. — v. 5(4). — p. 829−831.
- Pasi A., Mahler H., Lansel N., Bernasconi C., Messiha F.S. beta-Casomorphin-immunoreactivity in the brain stem of the human infant. // Res. Commun. Chem. Pathol. Pharmacol. 1993. — 80(3). — p. 305−322.
- Pedersen C.A., Caldwell J.D., Walker C., Ayers G., Mason G.A. Oxytocin activates the postpartum onset of rat maternal behavior in the ventral tegmental and medial preoptic areas. // Behav. Neurosci.- 1994. v. 108(6). — p. 1163−1171.
- Pepin M.C., Yue S.Y., Roberts E., Wahlestedt C., Walker P. Novel «restoration of function» mutagenesis strategy to identify amino acids of the delta-opioid receptor involved in ligand binding. // J. Biol. Chem. 1997.- v. 272(14). — p. 9260−9267.
- Peppard J.V., Jackson L.E., Hall J.G., Robertson D. The transfer of immune complexes from the lumen of the small intestine to the bloodstream in sucking rats. // Immunology. -1984.-v. 53(2). p. 385−393.
- Petrilli P., Addeo F., Chianese L. Primary structure of water buffalo beta-casein tryptic and CNBr peptides. // Ital. J. Biochem. 1983. — v. 32(5). — p. 336−344.
- Petrilli P., Picone D., Caporale C., Addeo F., Auricchio S., Marino G. Does casomorphin have a functional role? // FEBS Lett. 1984. — v. 169(1). — p. 53−56.
- Piatt D.M., Grech D.M.,-Rowlett J.K., Spealman R.D. Discriminative stimulus effects of morphine in squirrel monkeys: stimulants, opioids, and stimulant-opioid combinations. // J. Pharmacol. Exp. Ther. 1999. — v. 290(3). — p. 1092−1100.
- Polan H.J., Hofer M.A. Olfactory preference for mother over home nest shavings by newborn rats. // Dev. Psychobiol. 1998. — v. 33(1). — p. 5−20.
- Potaman V. N., Antonova L.V., Dubynin V.A., Zaitzev D.A., Kamensky A.A., Myasoedov N.F., Nezavibatko V.N. Entry of the synthesic ACTH (4−10) analogue into the rat brain following intravenous injection. // Neurosci.Lett. -1991.- v.127. p.133−136.
- Privette T.H., Terrian D.M. Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze. // Psychopharmacology (Berl.) 1995. — v. 118(4). — p. 444−450.
- Ramabadran K., Bansinath M. Opioid peptides from milk as a possible cause of sudden infant death syndrome. // Med. Hypotheses. 1988. — v. 27(3). — p. 181−187.
- Rauca C., Schroder H. Effect of BCH 325 (Pro-D-Phe-Pro-Gly) on central dopaminergic functions. // Peptides. 1995. — v. 16(4). p. 635−640.
- Read L.C., Lord A.P., Brantl V., Koch G. Absorption of beta-casomorphins from auto-perfused lamb and piglet small intestine. // Am. J. Physiol. -1990. v. 259. — p. 443−452.
- Reid L.D., Hubbell C.L. An assessment of the addiction potential of the opioid associatedwith milk. // J. Dairy Sci. 1994. — v. 77(3). — p. 672−675.
- Renlund S., Erlandsson I., Hellman U., Silberring J., Wernstedt C., Lindstrom L., Nyberg F. Micropurification and amino acid sequence of beta-casomorphin-8 in milk from a woman with postpartum psychosis. // Peptides.-1993.- v. 14(6). p. 1125−1132.
- Reymann K.G., Chepkova A.N., Matthies H. Effects of deprolorphin, a casomorphin analog, on hippocampal CA1 field potentials in vitro. // Peptides. 1983. — v. 4(3). — p. 283−286.
- Richardson B.C., Mercier J.C. The primary structure of the ovine beta-caseins. // Eur. J. Biochem. 1979. — v. 99(2). — p. 285−297.
- Robinson S.E., Maher J.R., Wallace M.J., Kunko P.M. Perinatal methadone exposure affects dopamine, norepinephrine, and serotonin in the weanling rat. // Neurotoxicol. Teratol. 1997. — v. 19(4). — p. 295−303.
- Rondeau D.B., Turcotte M., Young L., Hebert D. Similarities of the cataleptic state induced by beta-endorphin and morphine. // Pharmacol. Biochem. Behav. 1982. — v. 17(4). — p. 703−707.
- Rosenblatt J.S. Selective retrieving by maternal and nonmaternal female rats.// J Comp Physiol Psychol.- 1975.- v. 88(2). p. 678−686.
- Rosenblatt J.S. Psychobiology of maternal behavior: contribution to the clinical understanding of maternal behavior among humans. // Acta Paediatr. Suppl.- 1994. -v.39. p. 3−8. .
- Rosenblatt J.S., Mayer A.D., Giordano A.L. Hormonal basis during pregnancy for the onset of maternal behavior in the rat. // Psychoneuroendocrinology. 1988. — v. 13(1−2). -p. 29−46.
- Rossi G.C., Leventhal L., Bolan E., Pasternak G.W. Pharmacological characterization of orphanin FQ/nociceptin and its fragments. // J. Pharmacol. Exp. Ther. 1997. — v. 282(2). -p. 858−865.
- Roth T.L., Sullivan R.M. Consolidation and expression of a shock-induced odor preference in rat pups is facilitated by opioids. // Physiol Behav. 2003. — v.78(l). -p.135−142.
- Rubin B.S., Bridges R.S. Disruption of ongoing maternal responsiveness in rats by central administration of morphine sulfate. // Brain Res.- 1984. v. 307(1−2). — p.91−97.
- Ruthrich H.L., Grecksch G., Matthies H. Influence of beta-casomorphins on apomorphine-induced hyperlocomotion. // Pharmacol. Biochem. Behav. 1993 — v. 44(1). -p. 227−231.
- Ruthrich HL, Grecksch G, Matthies H. Adrenalectomy attenuates the improvement of memory in rats by peripheral application of Des-Tyr-D-Pro4-casomorphin. // Behav. Neural Biol. 1993 — v.59(l). — p.25−28.
- Ruthrich H.L., Grecksch G., Schmidt R. Phei-substituted beta-casomorphin-5 analogues with analgesic activity. // Peptides. 1994. — v. 15(3). — p. 457−460.
- Ruthrich H.L., Grecksch G., Schmidt R., Neubert K. Linear and cyclic beta-casomorphin analogues with high analgesic activity. // Peptides. 1992. — v. 13(3). — p. 483−485.
- Saha N., Datta H., Sharma P.L. Effects of morphine on memory: interactions with naloxone, propranolol and haloperidol. // Pharmacology. 1991. — v. 42(1). — p. 10−14.
- Sakaguchi M., Fujimori T., Satoh T., Satoh M., Takeuchi M., Matsumura E. Effects of opioids on neuronal survival in culture of embryonic chick dorsal root ganglion neurons. // Neurosci. Lett. 1999. — v. 262(1). — p. 17−20.
- Sakaguchi M., Murayama K., Yabe K., Satoh M., Takeuchi M., Matsumura E. Beta-casomorphin-5 stimulates neurite outgrowth in a mouse neuroblastoma cell line (Neuro-2a). // Neurosci Lett. 1998. — v. 251(2). — p. 97−100.
- Sakaguchi M., Murayama K., Jinsmaa Y., Yoshikawa M., Matsumura E. // Neurite outgrowth-stimulating activities of beta-casomorphins in Neuro-2a mouse neuroblastoma cells. // Biosci Biotechnol Biochem. 2003. — v. 67 (12). — p. 2541−2547.
- Sales N., Charnay Y., Zajac J.M., Dubois P.M., Roques B.P. Ontogeny of mu and delta opioid receptors and of neutral endopeptidase in human spinal cord: an autoradiographic study. // J. Chem. Neuroanat. 1989. — v. 2(4). — p. 179−188.
- Sanderson K., Nyberg F., Khalil Z. Modulation of peripheral inflammation by locally administered hemorphin-7. // Inflamm. Res. 1998. — v. 47(2). — p. 49−55. «
- Sandin J., Ogren S.O., Terenius L. Endomorphin-2 but not Leu-enkephalin modulates spatial learning when microinjected in the CA3 region of the rat hippocampus. // Neuroreport. 2000. — v. 11(17). — p. 3659−3662.
- Sanz Y., Toldra F. Purification and characterization of an X-prolyl-dipeptidyl peptidase from Lactobacillus sakei. //Appl. Environ. Microbiol. 2001. — v. 67(4). — p. 1815−1820.
- Scanff P., Yvon M., Thirouin S., Pelissier J.P. Characterization and kinetics of gastric emptying of peptides derived from milk proteins in the preruminant calf. // J. Dairy Res. -1992.-v. 59(4).-p. 437−447.
- Schiller P.W., Nguyen T. M, Maziak L.A., Wilkes B.C., Lemieux C. Structure-activity relationships of cyclic opioid peptide analogues containing a phenylalanine residue in the 3-position. //J. Med. Chem. 1987. — v. 30(11). — p. 2094−2099.
- Schmidt R., Neubert K., Barth A., Liebmann C., Schnittler M., Chung N.N., Schiller P.W. Structure-activity relationships of cyclic beta-casomorphin-5 analogues. // Peptides. -1991.- v. 12(6).-p. 1175−1180.
- Schreff M., Schulz S., Wiborny D., Hollt V. Immunofluorescent identification of endomorphin-2-containing nerve fibers and terminals in the rat brain and spinal cord. // Neuroreport. 1998. — v. 9(6). — p. 1031−1034.
- Schulte-Frohlinde E., Reindl W., Bierling D., Lersch C., Brantl V., Teschemacher H., Schusdziarra V. Effects of oral casokefamide on plasma levels, tolerance, and intestinal transit in man. // Peptides. 2000. — v. 21(3). — p. 439−442.
- Schusdziarra V., Henrichs I., Holland A., Klier M., Pfeiffer E.F. Evidence for an effect ofexorphins on plasma insulin and glucagon levels in dogs. // Diabetes. 1981. — 30. — N 4. -p. 362−364.
- Schusdziarra V., Schick A., de la Fuente A., Specht J., Klier M., Brantl V., Pfeiffer E.F. Effect of beta-casomorphins and analogs on insulin release in dogs. // Endocrinology. -1983a. v. 112(3). — p. 885−889.
- Schusdziarra V., Schick R, de la Fuente A., Holland A., Brantl V., Pfeiffer E.F. Effect of beta-casomorphins on somatostatin release in dogs. // Endocrinology. 1983b. — v. 112(6). -p. 1948−1951.
- Simmons M.L., Chavkin C. k-Opioid receptor activation of a dendrotoxin-sensitive potassium channel mediates presynaptic inhibition of mossy fiber neurotransmitter release. // Mol. Pharmacol. -1996. v. 50(1). — p. 80−85.
- Singh M., Rosen C.L., Chang K.J., Haddad G.G. Plasma beta-casomorphin-7 immunoreactive peptide increases after milk intake in newborn but not in adult dogs. // Pediatr. Res. 1989. — v. 26(1). — p. 34−38.
- Soaje M., de Di Nasso E.G., Deis R.P. Regulation by endogenous opioids of suckling-induced prolactin secretion in pregnant and lactating rats: role of ovarian steroids. II J Endocrinol. 2002. — v. 172(2). — p. 255−261.
- Spain J.W., Roth B.L., Coscia C.J. Differential ontogeny of multiple opioid receptors (mu, delta, and kappa). // J. Neurosci. 1985. — v. 5(3). — p. 584−588.
- Stark H., Lossner B., Matthies H. Degradation of beta-casomorphin in the rat brain in vivo. // Biomed. Biochim. Acta. 1986. — v. 45(4). — p. 557−563.
- Stark H., Lossner B., Matthies H. Metabolism of beta-casomorphin and its derivatives in rat brain and liver homogenates. // Biomed.Biochim.Acta.- 1987. v. 46(10). — p. 687−694.
- Stark H., Lossner B., Matthies H., Hartrodt B., Born I. Metabolism of D-proline beta-casomorphin derivatives in the rat brain. // Biomed. Biochim. Acta. 1988. — v. 47(9). — p. 865−869.
- Stark H., Van Bree J.B., de Boer A.G., Jaehde U., Breimer D.D. In vitro penetration of des-tyrosinel-D-phenylalanine3-beta-casomorphin across the blood-brain barrier. // Peptides. 1992.- v. 13(1). — p. 47−51.
- Stern J.M. Parturition influences initial pup preferences at later onset of maternal behavior in primiparous rats. // Physiol. Behav.- 1985. v. 35(1). — p.25−31.
- Stern J.M., Keer S.E. Maternal motivation of lactating rats is disrupted by low dosages of haloperidol. // Behav. Brain Res.- 1999. v. 99(2). — p.231 -239.
- Stern J.M.- Mackinnon DA. Sensory regulation of maternal behavior in rats: effects of pup age. // Dev. Psychobiol.- 1978. v. 11(6). — p. 579−586.
- Sun Z, Zhang Z, Wang X, Cade R, Elmir Z, Fregly M. Relation of beta-casomorphin to apnea in sudden infant death syndrome. //Peptides. — 2003. v. 24(6). — p.937−943.
- Szikra J., Benyhe S., Orosz G., Darula Z., Piot J.M., Fruitier I., Monory K., Hanoune J., Borsodi A. Radioligand binding properties of W-hemorphin 7, an atypical opioid peptide. // Biochem. Biophys. Res. Commun. 2001. — 281. — N 3. — p. 670−677.
- Taira T., Hilakivi L.A., Aalto J., Hilakivi I. Effect of beta-casomorphin on neonatal sleep in rats. // Peptides. 1990. — v. 11(1). — p. 1−4.
- Tanaka M., Yoshida M., Emoto H., Ishii H. Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies. // Eur. J. Pharmacol. 2000. — v. 405(1−3). — p. 397−406.
- Tavani A., Robson L.E., Kosterlitz H.W. Differential postnatal development of mu-, delta-and kappa-opioid binding sites in mouse brain, // Brain Res. 1985. — v. 355(2). — p. 306−309.
- Tenconi B., Lesma E., DiGiulio A.M., Gorio A. High opioid doses inhibit whereas low doses enhance neuritogenesis in PC 12 cells. // Brain Res. Dev. Brain Res. 1996. — v. 94(2).-p. 175−181.
- Teschemacher H., Koch G., Brantl V. Milk protein-derived opioid receptor ligands. // Biopolymers. 1997. — v. 43(2). — p. 99−117.
- Teschemacher H., Koch G., Scheffler H., Hildebrand A., Brantl V. Opioid peptides. Immunological significance? // Ann. N. Y. Acad. Sci. 1990. — v. 594. — p. 66−77.
- Thiels E., Alberts J.R., Cramer C.P., Weaning in rats: II. Pup behavior patterns. // Dev. Psychobiol. 1990. — v. 23(6). — p. 495−510.
- Tome D., Dumontier A.M., Hautefeuille M., Desjeux J.F. Opiate activity and transepithelial passage of intact beta-casomorphins in rabbit ileum. // Am. J. Physiol. -1987. v. 253(6 Pt 1). — p. 737−744.
- Trottier G., Srivastava L., Walker C.D. Etiology of infantile autism: a review of recent advances in genetic and neurobiological research. // J. Psychiat. Neurosci. 1999. — v. 24(2).-p. 103−115.
- Umbach M., Teschemacher H., Praetorius K., Hirschhauser R., Bostedt H. Demonstration of a beta-casomorphin immunoreactive material in the plasma of newborn calves after milk intake. // Regul. Pept. 1985. — v. 7. — p. 223−230.
- Vernotica E.M., Rosenblatt J.S., Morrell J.I. Microinfusion of cocaine into the medial preoptic area or nucleus accumbens transiently impairs maternal behavior in the rat. // Behav. Neurosci. 1999. — v. 113(2). — p. 377−390.
- Volterra A., Restani P., Brunello N., Galli C.L., Racagni G. Interaction of beta-casomorphins with multiple opioid receptors: in vitro and in vivo studies in the newborn rat brain. // Brain Res. 1986. — v. 395(1). — p. 25−30.
- Walsh C.J., Fleming A.S., Lee A., Magnusson J.E. The effects of olfactory andsomatosensory desensitization on Fos-like immunoreactivity in the brains of pup-exposed postpartum rats. // Behav. Neurosci. 1996. — v. 110(1). — p. 134−153.
- Wiedemann K., Jahn H., Kellner M. Effects of natriuretic peptides upon hypothalamo-pituitary-adrenocortical system activity and anxiety behaviour. // Exp. Clin. Endocrinol. Diabetes. 2000. — v. 108(1). — p. 5−13.
- Wilson C., Kaspar A. Changes in immobility responses in rat pups with maternal stimuli. //J. Gen. Psychol. -1994. v. 121(2). — p. l 11−120.
- White C.L., Bray G.A., York D.A. Intragastric beta-casomorphin (l-7) attenuates the suppression of fat intake by enterostatin. // Peptides. 2000. — v. 21(9). — p. 1377−1381.
- Wohltmann M., Roth B.L., Coscia CJ. Differential postnatal development of mu and delta opiate receptors. // Brain Res. 1982. — v. 255(4). — p. 679−684.
- Yang S., Yunden J., Sonoda S., Doyama N., Lipkowski A.W., Kawamura Y., Yoshikawa M. Rubiscolin, a delta selective opioid peptide derived from plant Rubisco. // FEBS Lett.- 2001. v. 509(2). — p.213−217.
- Yatskin O.N., Philippova M.M., Blishchenko E.Yu., Karelin A.A., Ivanov V.T. LW- and W-hemorphins: comparative levels in rat tissues. // FEBS Lett. 1998. — 428. — N 3. — p. 286−90.
- Yoshikawa M., Yoshimura T., Chiba H. Opioid peptides from human p-casein. // Agric. Biol. Chem. 1984. — v. 48. — p. 3185−3187.
- Zadina J.E., Hackler L., Ge L.J., Kastin A J. A potent and selective endogenous agonist for the mu-opiate receptor. // Nature. 1997. — v. 3. — suppl. 386(6624). — p. 499−502.
- Zagon I.S. Endogenous opioid systems and neural cancer: transmission and scanning electron microscopic studies of murine neuroblastoma in tissue culture. // Brain Res. Bull.- 1988. v. 21(5). -p. 777−784.
- Zagon I.S., Verderame M.F., Allen S.S., McLaughlin P.J. Cloning, sequencing, chromosomal location, and function of cDNAs encoding an opioid growth factor receptor (OGFr) in humans. // Brain Res. 2000. — v. 856(1−2). — p. 75−83.
- Zioudrou C., Streaty R.A., Klee W.A. Opioid peptides derived from food proteins. The exorphins. // J. Biol. Chem. 1979. — v. 254(7). — p. 2446−2449.